Back to Trades
Yu Yong
Chief Scientific OfficerCIK 0001937482
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 6
- Companies
- 1
- Active
- 2025–2026
Across 8 filings between 2025–2026, Yu Yong, Chief Scientific Officer, has disclosed $4.1M in transactions — all concentrated in GENELUX Corp (GNLX). Their disclosed trades are heavily weighted toward selling — $0 in buys and $48.6K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Sep 2 | GNLX GENELUX Corp | Yu Yong | Chief Scientific Officer | Sell | $26.7K |
| Aug 4 | GNLX GENELUX Corp | Yu Yong | Chief Scientific Officer | Sell | $1.9K |
| Jun 18 | GNLX GENELUX Corp | Yu Yong | Chief Scientific Officer | Grant | $0 |
| May 12 | GNLX GENELUX Corp | Yu Yong | Chief Scientific Officer | Sell | $1.8K |
| Mar 26 | GNLX GENELUX Corp | Yu Yong | SVP, Clinical Development | Sell | $2.2K |
| Dec 11 | GNLX GENELUX Corp | Yu Yong | SVP, Clinical Development | Sell | $16.0K |
| Sep 3 | GNLX GENELUX Corp | Yu Yong | SVP, Clinical Development | Award | $3.6M |
| Aug 29 | GNLX GENELUX Corp | Yu Yong | SVP, Clinical Development | Grant | $489.7K |
8 filings